$EYET Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EYETECH PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in EYETECH PHARMACEUTICALS INC. Get notifications about new insider transactions in EYETECH PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | D | 0.00 | 30,000 | 0 | 0 | 30 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | D | 0.00 | 1,178,239 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Sell | D | 0.00 | 25,000 | 0 | 0 | 25 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Sell | D | 0.00 | 229,000 | 0 | 0 | 229 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | D | 0.00 | 156,637 | 0 | 0 | 156.6 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | CARROLL CHRISTOPHER F | Chief Accounting Of ... | Sell | D | 0.00 | 46,800 | 0 | 0 | 46.8 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | D | 0.00 | 6,280 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | D | 0.00 | 6,280 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | D | 0.00 | 212,447 | 0 | 0 | 212.4 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Sell | D | 0.00 | 39,375 | 0 | 0 | 39.4 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | D | 0.00 | 154,495 | 0 | 0 | 154.5 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | Regan Michael J | Director | Sell | D | 0.00 | 37,500 | 0 | 0 | 37.5 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | SATOW PHILLIP M | Director | Sell | D | 0.00 | 37,500 | 0 | 0 | 37.5 K to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | M | 1.44 | 43,750 | 63,000 | 16,250 | |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Buy | M | 1.44 | 43,750 | 63,000 | 2,319,646 | 2.3 M to 2.3 M (+1.92 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Sell | D | 0.00 | 2,319,646 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Sell | D | 0.00 | 2,319,646 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 1.44 | 21,875 | 31,500 | 8,125 | |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Buy | M | 1.44 | 21,875 | 31,500 | 2,319,646 | 2.3 M to 2.3 M (+0.95 %) |
Nov 08 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Option Exercise | M | 1.44 | 30,000 | 43,200 | 0 | |
Nov 08 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Buy | M | 1.44 | 30,000 | 43,200 | 229,000 | 199 K to 229 K (+15.08 %) |
Nov 08 2005 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Option Exercise | M | 1.44 | 21,875 | 31,500 | 8,125 | |
Nov 08 2005 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Buy | M | 1.44 | 21,875 | 31,500 | 39,375 | 17.5 K to 39.4 K (+125.00 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | M | 1.44 | 21,875 | 31,500 | 8,125 | |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Buy | M | 1.44 | 21,875 | 31,500 | 2,319,646 | 2.3 M to 2.3 M (+0.95 %) |
Nov 16 2005 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Sell | D | 0.00 | 2,319,646 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 112,947 | 395,315 | 0 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 79,082 | 276,787 | 112,947 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 13,095 | 45,833 | 0 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 15,476 | 54,166 | 13,095 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 13,095 | 45,833 | 156,637 | 143.5 K to 156.6 K (+9.12 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 17.89 | 15,476 | 276,866 | 143,542 | 159 K to 143.5 K (-9.73 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 15,476 | 54,166 | 159,018 | 143.5 K to 159 K (+10.78 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 112,947 | 395,315 | 143,542 | 30.6 K to 143.5 K (+369.17 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 17.89 | 79,082 | 1,414,777 | 30,595 | 109.7 K to 30.6 K (-72.10 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 79,082 | 276,787 | 109,677 | 30.6 K to 109.7 K (+258.48 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 63,421 | 86,253 | 0 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 52,500 | 71,400 | 63,421 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 60,479 | 82,251 | 0 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 17.90 | 12,500 | 223,750 | 154,495 | 167 K to 154.5 K (-7.49 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 60,479 | 82,251 | 166,995 | 106.5 K to 167 K (+56.78 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 63,421 | 86,253 | 106,516 | 43.1 K to 106.5 K (+147.17 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 17.63 | 52,500 | 925,575 | 43,095 | 95.6 K to 43.1 K (-54.92 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 52,500 | 71,400 | 95,595 | 43.1 K to 95.6 K (+121.82 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Option Exercise | M | 1.36 | 45,377 | 61,713 | 0 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Option Exercise | M | 1.36 | 106,094 | 144,288 | 45,377 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Option Exercise | M | 1.36 | 57,105 | 77,663 | 0 | |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Buy | M | 1.36 | 57,105 | 77,663 | 212,447 | 155.3 K to 212.4 K (+36.76 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Buy | M | 1.36 | 45,377 | 61,713 | 155,342 | 110 K to 155.3 K (+41.26 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | S | 17.68 | 106,094 | 1,875,742 | 109,965 | 216.1 K to 110 K (-49.10 %) |
Nov 07 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Buy | M | 1.36 | 106,094 | 144,288 | 216,059 | 110 K to 216.1 K (+96.48 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 115,921 | |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 60,479 | |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 11.35 | 1,850 | 20,998 | 43,095 | 44.9 K to 43.1 K (-4.12 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 44,945 | 43.1 K to 44.9 K (+4.29 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 11.35 | 1,850 | 20,998 | 43,095 | 44.9 K to 43.1 K (-4.12 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 44,945 | 43.1 K to 44.9 K (+4.29 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | S | 11.35 | 5,325 | 60,439 | 109,965 | 115.3 K to 110 K (-4.62 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 2,800 | 9,800 | 192,029 | |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 11.33 | 2,800 | 31,724 | 30,595 | 33.4 K to 30.6 K (-8.38 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 2,800 | 9,800 | 33,395 | 30.6 K to 33.4 K (+9.15 %) |
Aug 01 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 11.33 | 15,600 | 176,748 | 1,178,239 | 1.2 M to 1.2 M (-1.31 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 2,800 | 9,800 | 194,829 | |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 12.68 | 2,800 | 35,504 | 30,595 | 33.4 K to 30.6 K (-8.38 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 2,800 | 9,800 | 33,395 | 30.6 K to 33.4 K (+9.15 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 117,771 | |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 62,329 | |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 12.59 | 1,850 | 23,292 | 43,095 | 44.9 K to 43.1 K (-4.12 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 44,945 | 43.1 K to 44.9 K (+4.29 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 12.59 | 1,850 | 23,292 | 43,095 | 44.9 K to 43.1 K (-4.12 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 44,945 | 43.1 K to 44.9 K (+4.29 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 117,771 | |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 62,329 | |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 12.59 | 1,850 | 23,292 | 43,095 | 44.9 K to 43.1 K (-4.12 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 44,945 | 43.1 K to 44.9 K (+4.29 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 12.59 | 1,850 | 23,292 | 43,095 | 44.9 K to 43.1 K (-4.12 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 44,945 | 43.1 K to 44.9 K (+4.29 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 12.56 | 15,600 | 195,936 | 1,193,839 | 1.2 M to 1.2 M (-1.29 %) |
Jul 01 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | S | 12.59 | 5,325 | 67,042 | 115,290 | 120.6 K to 115.3 K (-4.41 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Grant | A | 0.01 | 17,500 | 175 | 17,500 | 0 to 17.5 K |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Grant | A | 0.01 | 42,500 | 425 | 43,095 | 595 to 43.1 K (+7,142.86 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | SATOW PHILLIP M | Director | Grant | A | 0.01 | 37,500 | 375 | 37,500 | 0 to 37.5 K |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | Regan Michael J | Director | Grant | A | 0.01 | 37,500 | 375 | 37,500 | 0 to 37.5 K |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Director | Grant | A | 0.01 | 25,000 | 250 | 199,000 | 174 K to 199 K (+14.37 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Grant | A | 0.01 | 135,000 | 1,350 | 1,209,439 | 1.1 M to 1.2 M (+12.56 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Grant | A | 0.01 | 135,000 | 1,350 | 1,209,439 | 1.1 M to 1.2 M (+12.56 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Grant | A | 0.01 | 30,000 | 300 | 30,595 | 595 to 30.6 K (+5,042.02 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Grant | A | 0.01 | 92,500 | 925 | 120,615 | 28.1 K to 120.6 K (+329.01 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | CARROLL CHRISTOPHER F | Chief Accounting Of ... | Grant | A | 0.01 | 45,000 | 450 | 46,800 | 1.8 K to 46.8 K (+2,500.00 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Grant | A | 0.01 | 17,500 | 175 | 2,275,896 | 2.3 M to 2.3 M (+0.77 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Grant | A | 0.01 | 35,000 | 350 | 2,275,896 | 2.2 M to 2.3 M (+1.56 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 119,621 | |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Option Exercise | M | 1.36 | 1,850 | 2,516 | 64,179 | |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 12.94 | 1,850 | 23,939 | 595 | 2.4 K to 595 (-75.66 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 2,445 | 595 to 2.4 K (+310.92 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Sell | S | 12.94 | 1,850 | 23,939 | 595 | 2.4 K to 595 (-75.66 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | SBLENDORIO GLENN | Chief Financial Off ... | Buy | M | 1.36 | 1,850 | 2,516 | 2,445 | 595 to 2.4 K (+310.92 %) |
Jun 30 2005 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.01 | 17,500 | 175 | 2,275,896 | 2.3 M to 2.3 M (+0.77 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 2,800 | 9,800 | 197,629 | |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 12.98 | 2,800 | 36,344 | 595 | 3.4 K to 595 (-82.47 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 2,800 | 9,800 | 3,395 | 595 to 3.4 K (+470.59 %) |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 12.95 | 15,600 | 202,020 | 1,074,439 | 1.1 M to 1.1 M (-1.43 %) |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 23.31 | 25,000 | 582,750 | 25,000 | |
Jun 03 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | S | 12.95 | 5,325 | 68,959 | 28,115 | 33.4 K to 28.1 K (-15.92 %) |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | Regan Michael J | Director | Option Exercise | A | 23.31 | 25,000 | 582,750 | 25,000 | |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | SATOW PHILLIP M | Director | Option Exercise | A | 23.31 | 25,000 | 582,750 | 25,000 | |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | SIMON HENRY | Director | Option Exercise | A | 23.31 | 25,000 | 582,750 | 25,000 | |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | WICKER DAMION E MD | Director | Option Exercise | A | 23.31 | 25,000 | 582,750 | 25,000 | |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 23.31 | 25,000 | 582,750 | 10,000 | |
May 13 2005 | EYET | EYETECH PHARMACEUT ... | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | A | 23.31 | 50,000 | 1,165,500 | 50,000 | |
May 03 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Sell | S | 23.73 | 50,000 | 1,186,500 | 174,000 | 224 K to 174 K (-22.32 %) |
Apr 01 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Sell | S | 27.50 | 50,000 | 1,375,000 | 224,000 | 274 K to 224 K (-18.25 %) |
Mar 01 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Sell | S | 32.78 | 50,000 | 1,639,000 | 274,000 | 324 K to 274 K (-15.43 %) |
Feb 07 2005 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 6,000 | 21,000 | 11,262 | |
Feb 07 2005 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Buy | M | 3.50 | 6,000 | 21,000 | 6,333 | 333 to 6.3 K (+1,801.80 %) |
Feb 03 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 35.97 | 100,000 | 3,597,000 | 1,090,039 | 1.2 M to 1.1 M (-8.40 %) |
Feb 02 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 4,000 | 14,000 | 200,429 | |
Feb 02 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 36.45 | 4,000 | 145,800 | 0 | 4 K to 0 (-100.00 %) |
Feb 02 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 4,000 | 14,000 | 4,000 | 0 to 4 K |
Feb 02 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Sell | S | 36.07 | 20,000 | 721,400 | 324,000 | 344 K to 324 K (-5.81 %) |
Feb 02 2005 | EYET | EYETECH PHARMACEUT ... | GLICK MARTY | Director | Sell | S | 36.15 | 6,600 | 238,590 | 533,400 | 540 K to 533.4 K (-1.22 %) |
Jan 31 2005 | EYET | EYETECH PHARMACEUT ... | GLICK MARTY | Director | Option Exercise | S | 40.00 | 237 | 9,480 | 0 | |
Jan 13 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Sell | S | 44.70 | 40,000 | 1,788,000 | 1,169,500 | 1.2 M to 1.2 M (-3.31 %) |
Jan 20 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Sell | S | 39.83 | 50,000 | 1,991,500 | 344,000 | 394 K to 344 K (-12.69 %) |
Jan 13 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Sell | S | 44.71 | 20,000 | 894,200 | 394,000 | 414 K to 394 K (-4.83 %) |
Jan 06 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Payment of Exercise | F | 42.63 | 4,461 | 190,172 | 1,230,039 | 1.2 M to 1.2 M (-0.36 %) |
Jan 06 2005 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Grant | A | 0.01 | 25,000 | 250 | 1,234,500 | 1.2 M to 1.2 M (+2.07 %) |
Jan 06 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Payment of Exercise | F | 42.63 | 6,479 | 276,200 | 32,845 | 39.3 K to 32.8 K (-16.48 %) |
Jan 06 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Grant | A | 0.01 | 20,000 | 200 | 39,324 | 19.3 K to 39.3 K (+103.50 %) |
Jan 05 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Option Exercise | M | 1.36 | 8,212 | 11,168 | 57,105 | |
Jan 05 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Option Exercise | M | 1.36 | 8,212 | 11,168 | 65,317 | |
Jan 05 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | S | 43.45 | 8,212 | 356,811 | 19,324 | 27.5 K to 19.3 K (-29.82 %) |
Jan 05 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Buy | M | 1.36 | 8,212 | 11,168 | 27,536 | 19.3 K to 27.5 K (+42.50 %) |
Jan 05 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Sell | S | 45.21 | 8,212 | 371,265 | 19,324 | 27.5 K to 19.3 K (-29.82 %) |
Jan 05 2005 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Buy | M | 1.36 | 8,212 | 11,168 | 27,536 | 19.3 K to 27.5 K (+42.50 %) |
Jan 04 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Option Exercise | A | 45.00 | 42,292 | 1,903,140 | 42,292 | |
Jan 04 2005 | EYET | EYETECH PHARMACEUT ... | PATEL SAMIR CHANDRAKANT | Chief Commercial & ... | Option Exercise | A | 45.00 | 7,708 | 346,860 | 7,708 | |
Jan 04 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Option Exercise | M | 3.50 | 4,000 | 14,000 | 204,429 | |
Jan 04 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Sell | S | 45.19 | 4,000 | 180,760 | 0 | 4 K to 0 (-100.00 %) |
Jan 04 2005 | EYET | EYETECH PHARMACEUT ... | CHANEY PAUL G | Chief Operating Off ... | Buy | M | 3.50 | 4,000 | 14,000 | 4,000 | 0 to 4 K |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ADAMIS ANTHONY P | Chief Scientific Of ... | Option Exercise | A | 43.55 | 165,000 | 7,185,750 | 165,000 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | A | 43.55 | 25,000 | 1,088,750 | 25,000 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 21,024 | 73,584 | 105,405 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Option Exercise | M | 3.50 | 2,976 | 10,416 | 17,262 | |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Sell | S | 43.58 | 21,024 | 916,226 | 333 | 21.4 K to 333 (-98.44 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Buy | M | 3.50 | 21,024 | 73,584 | 21,357 | 333 to 21.4 K (+6,313.51 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Sell | S | 43.58 | 2,976 | 129,694 | 333 | 3.3 K to 333 (-89.94 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Buy | M | 3.50 | 2,976 | 10,416 | 3,309 | 333 to 3.3 K (+893.69 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | ALTSCHULER DOUGLAS H | Sr VP, Legal, Gener ... | Sell | S | 43.58 | 8,000 | 348,640 | 333 | 8.3 K to 333 (-96.00 %) |
Dec 21 2004 | EYET | EYETECH PHARMACEUT ... | GUYER DAVID R | Chief Executive Off ... | Option Exercise | A | 43.55 | 250,000 | 10,887,500 | 250,000 |